Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Flyte Aviation, Inc.RMED · Entity 8648 | Director | June 04, 2021 | June 08, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Flyte Aviation, Inc.
Report date June 04, 2021 · Filed June 08, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,766 |
Reported balance
After 2021-06-04 transaction · row 1
1 source rowRow 1 · 2021-06-04 · Grant · Acquired 4,000 · Balance 18,766 F1: Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) June 4, 2022, or (ii) the day prior to the date of the Stockholder's Annual Meeting next following June 4, 2021, subject to the reporting person's continued service. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 5,263 |
Reported balance
Holding disclosure · report date 2021-06-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,263 F2: Shares held of record by the Enquist Family Trust UAD 12/13/1990, for which the reporting person serves as trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) June 4, 2022, or (ii) the day prior to the date of the Stockholder's Annual Meeting next following June 4, 2021, subject to the reporting person's continued service.
F2: Shares held of record by the Enquist Family Trust UAD 12/13/1990, for which the reporting person serves as trustee.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
EndoChoice Holdings, Inc.
Report date November 22, 2016 · Filed November 23, 2016
Section 16 reporting ended · disclosed 2016-11-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.001 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-11-22 transaction · row 1
1 source rowRow 1 · 2016-11-22 · Disposition to issuer · Disposed 29,443 · Balance 0 F1: Reporting Person disposed of shares of Issuer Common Stock pursuant to a cash tender offer made by Boston Scientific Corporation as more fully described in the Schedule 14D-9 filed by Issuer with the Securities and Exchange Commission on October 7, 2016, and subsequent amendments thereto (the "Merger"). The Issuer's Board of Directors approved in advance the dispositions by the Reporting Person in the tender offer. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting Person disposed of shares of Issuer Common Stock pursuant to a cash tender offer made by Boston Scientific Corporation as more fully described in the Schedule 14D-9 filed by Issuer with the Securities and Exchange Commission on October 7, 2016, and subsequent amendments thereto (the "Merger"). The Issuer's Board of Directors approved in advance the dispositions by the Reporting Person in the tender offer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2021 Filed Jun 8, 2021 20:02 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039050 · doc4.xml · nonDerivative · entry 1 ENQUIST WILLIAM R · CIK 0001659002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,766 F1 · shares: Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) June 4, 2022, or (ii) the day prior to the date of the Stockholder's Annual Meeting next following June 4, 2021, subject to the reporting person's continued service. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 18:13 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 7,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002585 · doc4.xml · nonDerivative · entry 1 ENQUIST WILLIAM R · CIK 0001659002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,766 F1 · shares: The Reporting Person has elected to receive his 2021 retainer compensation in restricted stock, rather than cash. Subject to the Reporting Person continuing to be a "Service Provider" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date, the shares shall vest as follows: 25% of the shares subject to the restricted stock award shall vest quarterly on the fifth of the month immediately following the end of the quarter corresponding with the date of grant (i.e. April 5, 2021, July 5, 2021, October 5, 2021, and January 5, 2022), such that the shares shall be fully vested on January 5, 2022. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 18:04 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | PurchaseCommon Stock | 5,263 | $5.82 | $30,621.71 |
DisclosureSEC source: 0001209191-20-060058 · doc4.xml · nonDerivative · entry 1 ENQUIST WILLIAM R · CIK 0001659002 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,263 F1 · price: Represents the weighted average share price of an aggregate total of 5,263 shares purchased in the price range of $5.71 to $5.95 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: Shares held of record by the Enquist Family Trust UAD 12/13/1990, for which the reporting person serves as trustee. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 17:39 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-054812 · doc4.xml · nonDerivative · entry 1 ENQUIST WILLIAM R · CIK 0001659002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,085 F1 · shares: Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) October 12, 2021, or (ii) the day prior to the date of the Annual Meeting next following October 12, 2020, subject to the reporting person's continued service. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 17:57 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | PurchaseCommon Stock | 50,000 | $0.47 | $23,700.00 |
DisclosureSEC source: 0001209191-20-033288 · doc4.xml · nonDerivative · entry 1 ENQUIST WILLIAM R · CIK 0001659002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,085 Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 17:38 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantStock Option (Right to Buy) · Derivative | 43,644 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-20-002577 · doc4.xml · derivative · entry 1 ENQUIST WILLIAM R · CIK 0001659002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,644 Underlying: Common Stock · 43,644 shares Expires 2030-01-06 F1 · derivative.exercise_date: The Reporting Person has elected to receive his 2020 retainer compensation in stock option grants, rather than cash. Subject to the Reporting Person continuing to be a "Service Provider" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date, the shares shall vest as follows: 25% of the shares subject to the option shall vest quarterly on the fifth of the month immediately following the end of the quarter corresponding with the date of grant (i.e. April 5, 2020, July 5, 2020, October 5, 2020, and January 5, 2021), such that the shares shall be fully vested on January 5, 2021. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 17:47 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 29,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035629 · doc4.xml · nonDerivative · entry 1 ENQUIST WILLIAM R · CIK 0001659002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,085 F1 · shares: Reported shares represents a grant of restricted stock units (the "RSUs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSUs will vest on the earlier of (i) June 6, 2020, or (ii) the day prior to the date of the Annual Meeting next following June 6, 2019, subject to the reporting person's continued service. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:18 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 8,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-054441 · doc4.xml · nonDerivative · entry 1 ENQUIST WILLIAM R · CIK 0001659002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,235 F1 · shares: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 1/3rd of the RSUs shall vest annually beginning on October 4, 2019 such that the RSUs will be fully vested on October 4, 2021, subject to the reporting person's continued service. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 10:21 UTC | EndoChoice Holdings, Inc. GI · Entity 180876 | Disposition to issuerCommon stock, par value $0.001 per share | 29,443 | $8.00 | $235,544.00 |
DisclosureSEC source: 0001623919-16-000097 · wf-form4_147991448056349.xml · nonDerivative · entry 1 ENQUIST WILLIAM R · CIK 0001659002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · acquired: Reporting Person disposed of shares of Issuer Common Stock pursuant to a cash tender offer made by Boston Scientific Corporation as more fully described in the Schedule 14D-9 filed by Issuer with the Securities and Exchange Commission on October 7, 2016, and subsequent amendments thereto (the "Merger"). The Issuer's Board of Directors approved in advance the dispositions by the Reporting Person in the tender offer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.